Christos Varelas, MD, MSc1*, Efthymia Vlachaki, MBBS2*, Filippos Klonizakis, MD3*, Despoina Pantelidou, MD, PhD4*, Fani Minti5*, Michael D. Diamantidis, MD, PhD, MSc6, Nikolaos Sampanis7*, Ioanna Giatagantzidou8*, Despoina Papadopoulou, MD4*, Evdoxia Koravou9*, Ioanna Christodoulou5*, Evaggelia Zarkada5*, Tasoula Touloumenidou10*, Apostolia Papalexandri9*, Ioanna Sakellari11*, George Vassilopoulos, MD, PhD12, Robert Brodsky, MD13 and Eleni Gavriilaki, MD, PhD14
1Hematology Department - HCT Unit, George Papanikolaou Hospital, Thessaloniki, Greece
2Adults Thalassemia Unit, Hippokration Hospital, Thessaloníki Thalassemia Therapy and Sickle Cell Disease Unit, Thessaloniki, Greece
3Adults Thalassemia Unit, Hippokration Hospital, Thessaloníki Thalassemia Therapy and Sickle Cell Disease Unit, Thessaloniki, AL, Greece
4Thalassemia and Sickle Cell Disease Unit, AHEPA University Hospital, Thessaloniki, Thessaloniki, Greece
5Aristotle University of Thessaloniki, Thessaloniki, Greece
6Thalassemia and Sickle Cell Disease Unit, General Hospital of Larissa, Larissa, Greece
7General Hospital of Trikala, Trikals
8AHEPA Hospital, Thessaloniki, Greece
9Department of Hematology and HCT Unit, G. Papanikolaou Hospital, Thessaloniki, Greece
10Hematology Department and HCT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece
11Hematology Department and HCT Unit, George Papanikolaou General Hospital, THESSALONIKI, AL, Greece
12Cell and Gene Therapy Group, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
13Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD
142nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece